Subscribe
court
BCFC / iStockphoto.com
5 September 2017Americas

Federal Circuit denies CardiAQ injunction request against Neovasc

The US Court of Appeals for the Federal Circuit has affirmed a district court decision which stated that CardiAQ is not entitled to injunctive relief, despite a $91 million damages payout from Neovasc.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Federal Circuit affirms district court’s Bayer ruling
2 March 2017   The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.
Medtech
Neovasc adds two co-inventors to heart valve patents
23 April 2019   Medical device company Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor, Edwards Lifesciences.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

More on this story

Americas
Federal Circuit affirms district court’s Bayer ruling
2 March 2017   The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.
Medtech
Neovasc adds two co-inventors to heart valve patents
23 April 2019   Medical device company Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor, Edwards Lifesciences.

More on this story

Americas
Federal Circuit affirms district court’s Bayer ruling
2 March 2017   The US Court of Appeals for the Federal Circuit has partially affirmed a ruling by a district court in a patent dispute between Bayer and Dow Agrosciences.
Medtech
Neovasc adds two co-inventors to heart valve patents
23 April 2019   Medical device company Neovasc has added two co-inventors to three of its patents, settling a dispute with a competitor, Edwards Lifesciences.

More features

Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott
‘A marathon and a sprint at the same time’: How we won $452m damages